Freeport-McMoRan presents a curious tension this week. Analysts are raising targets and copper demand is strong, yet every insider transaction in the past 90 days has been a sell — and the stock gave back 2.3% on Tuesday even as the monthly trend remains firmly up.
The insider selling is the most specific signal worth examining here. The pattern is consistent rather than scattered: the Chief Administration Officer, Chief Accounting Officer, CFO, President, Chairman, and General Counsel all sold shares in February, and the CAO and CAO returned for more in late July and early August at prices near $69–$70. Net insider sales over the past 90 days amount to roughly 26,600 shares valued at about $1.8 million. None of these are large relative to the company's float, and trade significance scores are uniformly low. But the direction is unambiguous — no buying, only selling — at a moment when the stock has rallied 12% in a month and sits near what analysts describe as fair value.
The lending market tells a very different story from one under any short pressure. Availability is effectively unlimited — well over 9,000% relative to shares already borrowed — meaning shares to borrow are abundant for anyone who wants to build a short position. The cost to borrow is negligible, running around 0.37%, down slightly on the week. Short interest itself is modest at roughly 2% of free float and has actually trended lower over the past six weeks, falling from around 31 million shares in mid-July to 28 million now. Options positioning is similarly relaxed: the put/call ratio at 1.01 is a touch below its 20-day average of 1.03, suggesting no unusual demand for downside protection. The overall short score of 30.7 is low and has barely moved in two weeks. This is not a setup where bearish traders are making a strong statement.
The Street, by contrast, has been making a bullish statement — though with a few caveats worth noting. The bulk of analyst action following Q2 earnings on July 23 was constructive: Barclays raised its target to $82 (Overweight), Wells Fargo lifted to $70, and RBC moved to $73 — all maintaining existing positive ratings. JPMorgan and BofA had already raised targets in early July, to $77 and $80 respectively, ahead of the print. Goldman Sachs is the lone dissenter in recent weeks, trimming its target by $1 to $74 while holding a Buy. The consensus mean target of around $71.73 sits only modestly above the current price of $68.87, implying limited upside on the numbers alone. On valuation, the EV/EBITDA multiple has contracted slightly over the past week to 7.7x, though it is up roughly 1.3 P/E turns over the past month as the stock has run. Factor scores reflect a stock where momentum and earnings revision quality are strong — EPS momentum ranks in the 84th percentile on a 90-day basis and the 75th on 30 days — but value is average at best, with the EV/EBIT factor ranking at just the 42nd percentile. The bull case rests on Grasberg's long-runway production profile and the life-of-resource extension with Indonesia. The bear case is a familiar one for commodities names: the stock trades at a premium to peers and copper prices remain volatile.
The Q2 earnings result itself was not well received. The stock fell 3.7% the day after the July 23 print and was still down 2.4% five days later — a reminder that even when the fundamental story is intact, execution against elevated expectations is a high bar. The next earnings event lands on October 23. Between now and then, the dominant themes to watch are copper price moves — which will drive both the fundamental outlook and the tone of any analyst revisions — and whether the ongoing pattern of insider selling at elevated prices continues or moderates as the stock approaches the range of analyst targets.
See the live data behind this article on ORTEX.
Open FCX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
